Cargando…
Pharmacogenomics Guided-Personalization of Warfarin and Tamoxifen
The use of pharmacogenomics to personalize drug therapy has been a long-sought goal for warfarin and tamoxifen. However, conflicting evidence has created reason for hesitation in recommending pharmacogenomics-guided care for both drugs. This review will provide a summary of the evidence to date on t...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748632/ https://www.ncbi.nlm.nih.gov/pubmed/29236081 http://dx.doi.org/10.3390/jpm7040020 |
_version_ | 1783289436775120896 |
---|---|
author | Wigle, Theodore J. Jansen, Laura E. Teft, Wendy A. Kim, Richard B. |
author_facet | Wigle, Theodore J. Jansen, Laura E. Teft, Wendy A. Kim, Richard B. |
author_sort | Wigle, Theodore J. |
collection | PubMed |
description | The use of pharmacogenomics to personalize drug therapy has been a long-sought goal for warfarin and tamoxifen. However, conflicting evidence has created reason for hesitation in recommending pharmacogenomics-guided care for both drugs. This review will provide a summary of the evidence to date on the association between cytochrome P450 enzymes and the clinical end points of warfarin and tamoxifen therapy. Further, highlighting the clinical experiences that we have gained over the past ten years of running a personalized medicine program, we will offer our perspectives on the utility and the limitations of pharmacogenomics-guided care for warfarin and tamoxifen therapy. |
format | Online Article Text |
id | pubmed-5748632 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-57486322018-01-07 Pharmacogenomics Guided-Personalization of Warfarin and Tamoxifen Wigle, Theodore J. Jansen, Laura E. Teft, Wendy A. Kim, Richard B. J Pers Med Review The use of pharmacogenomics to personalize drug therapy has been a long-sought goal for warfarin and tamoxifen. However, conflicting evidence has created reason for hesitation in recommending pharmacogenomics-guided care for both drugs. This review will provide a summary of the evidence to date on the association between cytochrome P450 enzymes and the clinical end points of warfarin and tamoxifen therapy. Further, highlighting the clinical experiences that we have gained over the past ten years of running a personalized medicine program, we will offer our perspectives on the utility and the limitations of pharmacogenomics-guided care for warfarin and tamoxifen therapy. MDPI 2017-12-13 /pmc/articles/PMC5748632/ /pubmed/29236081 http://dx.doi.org/10.3390/jpm7040020 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Wigle, Theodore J. Jansen, Laura E. Teft, Wendy A. Kim, Richard B. Pharmacogenomics Guided-Personalization of Warfarin and Tamoxifen |
title | Pharmacogenomics Guided-Personalization of Warfarin and Tamoxifen |
title_full | Pharmacogenomics Guided-Personalization of Warfarin and Tamoxifen |
title_fullStr | Pharmacogenomics Guided-Personalization of Warfarin and Tamoxifen |
title_full_unstemmed | Pharmacogenomics Guided-Personalization of Warfarin and Tamoxifen |
title_short | Pharmacogenomics Guided-Personalization of Warfarin and Tamoxifen |
title_sort | pharmacogenomics guided-personalization of warfarin and tamoxifen |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748632/ https://www.ncbi.nlm.nih.gov/pubmed/29236081 http://dx.doi.org/10.3390/jpm7040020 |
work_keys_str_mv | AT wigletheodorej pharmacogenomicsguidedpersonalizationofwarfarinandtamoxifen AT jansenlaurae pharmacogenomicsguidedpersonalizationofwarfarinandtamoxifen AT teftwendya pharmacogenomicsguidedpersonalizationofwarfarinandtamoxifen AT kimrichardb pharmacogenomicsguidedpersonalizationofwarfarinandtamoxifen |